Thursday broker round-up
(Sharecast News) - Hargreaves Lansdown: Deutsche Bank downgrades to sell with a target price of 1,325p.
Read more(Sharecast News) - Hargreaves Lansdown: Deutsche Bank downgrades to sell with a target price of 1,325p.
Read more* Oxford clinical trial is latest of handful already begun* Three European firms join forces for vaccine research* Swiss company hopes to get vaccine into use this yearBy Kate KellandLONDON, April 23 (Reuters) - Scientists in Britain began clinical ...
Read moreTOP NEWS: Unilever Says Home Products Buying Offsets Ice Cream Slump
Read more* For patients with existing heart, kidney condition* Tests if Farxiga cuts risk of disease worsening, death* Company has announced trial with Calquence for COVID-19 (Recasts with details on trial, competitors, context)By Pushkala AripakaApril 23 (R...
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreLONDON, April 17 (Reuters) - Britain launched a new coronavirus taskforce on Friday to support efforts to make a vaccine available to the public as quickly as possible.The government said 21 new research projects would get funding from a 14 millio...
Read more(For a live blog on European stocks, type LIVE/ in an Eikon news window)* FTSE 100 up 0.6%, FTSE 250 adds 0.2%* Britain extends lockdown for at least three weeks* Retail spending slumps in first two weeks of lockdown measures* EasyJet reverses earl...
Read more(Sharecast News) - Almost one-third of FTSE 100 companies have cut or scrapped their dividends during the coronavirus crisis, leaving investors relying on 10 companies for two-thirds of the index's likely payouts in 2020, research shows.
Read more(Adds details and quote)LONDON, April 15 (Reuters) - The world will need more than one COVID-19 vaccine so drug companies must partner in the race to develop the weapons to fight the novel coronavirus, GlaxoSmithKline Chief Executive Officer Emma ...
Read moreLONDON, April 15 (Reuters) - The world will need more than one COVID-19 vaccine so drug companies must partner in the race to develop the weapons to fight the novel coronavirus, GlaxoSmithKline Chief Executive Officer Emma Walmsley said on Wednes...
Read more14 aprile (Reuters) - GlaxoSmithKline Plc e Sanofi SA hanno annunciato che svilupperanno un vaccino contro il Covid-19.Le due case farmaceutiche prevedono l'inizio dei test clinici per il vaccino nella seconda metà dell'anno. In caso di successo,...
Read moreTOP NEWS: Glaxo Partners With Sanofi To Develop Covid-19 Vaccine
Read more(Sharecast News) - GlaxoSmithKline said it was working with Sanofi of France on a Covid-19 vaccine that could be ready by the second half of 2021.
Read more(Adds detail on Calquence, background)By Aakash BApril 14 (Reuters) - AstraZeneca Plc said on Tuesday it would start a clinical trial of its cancer drug Calquence to assess its potential to control the exaggerated immune system response associated...
Read moreCovid-19 Antibody Test Could Be Scaled Up By May End Says AstraZeneca
Read more